Literature DB >> 3264944

Psychosocial effects of screening for somatic risk: the Swedish alpha 1 antitrypsin experience.

T F McNeil1, T Sveger, T Thelin.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3264944      PMCID： PMC461352          DOI： 10.1136/thx.43.7.505

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  14 in total

1.  Psychological factors in cost-benefit analysis of somatic prevention. A study of the psychological effects of neonatal screening for alpha 1-antitrypsin deficiency.

Authors:  T F McNeil; T Thelin; E Aspegren-Jansson; T Sveger; B Harty
Journal:  Acta Paediatr Scand       Date:  1985-05

2.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors:  T Sveger
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

3.  Psychological consequences of neonatal screening for alpha 1-antitrypsin deficiency. Parental reactions to the first news of their infants' deficiency.

Authors:  T Thelin; T F McNeil; E Aspegren-Jansson; T Sveger
Journal:  Acta Paediatr Scand       Date:  1985-09

4.  A risk group's visits to medical services: five years' usage of well-baby and medical clinics by a group of children with alpha 1-antitrypsin deficiency.

Authors:  T Sveger; T Thelin; T McNeil
Journal:  Acta Paediatr Scand       Date:  1985-09

5.  Identifying children at high somatic risk: possible long-term effects on the parents' views of their own health and current life situation.

Authors:  T Thelin; T F McNeil; E Aspegren-Jansson; T Sveger
Journal:  Acta Psychiatr Scand       Date:  1985-06       Impact factor: 6.392

6.  Identifying children at high somatic risk: parents' long-term emotional adjustment to their children's alpha 1 antitrypsin deficiency.

Authors:  T Thelin; T F McNeil; E Aspegren-Jansson; T Sveger
Journal:  Acta Psychiatr Scand       Date:  1985-10       Impact factor: 6.392

7.  Identifying children at high somatic risk (alpha 1 antitrypsin deficiency): possible long-term effects on parents' reproduction, marital status and social class level.

Authors:  T Thelin; T F McNeil; T Sveger
Journal:  Acta Psychiatr Scand       Date:  1985-06       Impact factor: 6.392

8.  Identifying children at high somatic risk: possible long-term effects on the parents' attitudes and feelings associated with the child.

Authors:  T F McNeil; T Thelin; E Aspegren-Jansson; T Sveger
Journal:  Acta Psychiatr Scand       Date:  1986-10       Impact factor: 6.392

9.  Identifying children at high somatic risk: long-term effects on mother-child interaction.

Authors:  T F McNeil; B Harty; T Thelin; E Aspegren-Jansson; T Sveger
Journal:  Acta Psychiatr Scand       Date:  1986-12       Impact factor: 6.392

10.  Identifying children at high somatic risk: possible long-term effects on the parents' relationship to the child.

Authors:  T F McNeil; T Thelin; E Aspegren-Jansson; T Sveger
Journal:  Acta Psychiatr Scand       Date:  1986-10       Impact factor: 6.392
View more
  6 in total

1.  The ethics and impact on behaviour of knowledge about one's own genome. Interview by Judy Jones.

Authors:  M Levitt
Journal:  BMJ       Date:  1999-11-13

2.  Illness causal attributions: an exploratory study of their structure and associations with other illness cognitions and perceptions of control.

Authors:  Shoshana Shiloh; Dana Rashuk-Rosenthal; Yael Benyamini
Journal:  J Behav Med       Date:  2002-08

Review 3.  Biochemical neonatal screening.

Authors:  B Modell
Journal:  BMJ       Date:  1990-06-30

4.  Criteria for alpha 1-antitrypsin substitution.

Authors:  K Viskum; A Kok-Jensen
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 5.  Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

6.  Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.

Authors:  N Seersholm; A Kok-Jensen
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.